Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 29.01.2026 KNG.LN IE000SNMGYT5 250,002.00 USD 5,259,522.08 21.038  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 29.01.2026 GNOV LN IE000OJ31JQ4 1,050,002.00 USD 37,079,831.55 35.314  ...
-

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System

PARIS--(BUSINESS WIRE)--Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are...
-

Riassunto: Comunicato stampa: Jannik Sinner e Allianz annunciano una collaborazione globale pluriennale

MONACO--(BUSINESS WIRE)--Oggi la star del tennis Jannik Sinner e Allianz Group hanno annunciato una collaborazione pluriennale a livello globale, con la compagnia di assicurazioni e gestore patrimoniale leader nel settore che diventa partner ufficiale del quattro volte campione di Grand Slam. Forte di circa 300 milioni di fan in tutto il mondo e un miliardo di fan ATP a livello globale, il tennis è il secondo sport più popolare al mondo dopo il calcio nei mercati chiave di Allianz. Il testo ori...
-

Communiqué de presse : Jannik Sinner et Allianz annoncent un partenariat mondial pluriannuel

MUNICH--(BUSINESS WIRE)--La star du tennis Jannik Sinner et le groupe Allianz ont annoncé aujourd’hui un partenariat mondial pluriannuel, le leader de l’assurance et de la gestion d’actifs devenant le partenaire officiel du quadruple vainqueur du Grand Chelem. Avec environ 300 millions de fans dans le monde et un milliard de fans de l’ATP, le tennis est le deuxième sport le plus populaire derrière le football sur les principaux marchés d’Allianz. L’un des piliers de cette collaboration est l’au...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2976285937 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 3,500,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2987788580 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 1,000,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

YOUNG & CO'S BREWERY PLC UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  30 January 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 29 January 2026, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Peel Hunt LLP (“Peel Hun...
-

HSBC Bank Plc UK Regulatory Announcement: Early Repurchase(s)

LONDON--(BUSINESS WIRE)--  ISIN XS2989338616 Issuer Name HSBC Bank Plc Paying Agent HSBC Bank plc Redemption Type Repurchase Currency USD O/S Balance 75,000.00 New Balance 0.00 Value Date 28-Jan-26  ...
-

Merz Therapeutics Appoints Dan Staner as President, Region Europe

FRANKFURT, Germany--(BUSINESS WIRE)--Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerati...